Publications Scientifiques

[ Article ] Sclerocarya Birrea (Anacardiaceae) Stem-Bark Extract Stimulates Protein Kinase Akt And AMPK Pathways in The Liver in a Diet-Induced Obesity Mouse Model.

Date de soumission: 30-03-2017
Année de Publication: 2015
Entité/Laboratoire Laboratoire de Biomembranes et Signalisation Cellulaire (LBSC)
Document type : Article
Discipline(s) : Pharmacie, Pharmacologie & Toxicologie
Titre Sclerocarya Birrea (Anacardiaceae) Stem-Bark Extract Stimulates Protein Kinase Akt And AMPK Pathways in The Liver in a Diet-Induced Obesity Mouse Model.
Auteurs Attakpa Sèlidji Eugène [1], SEZAN ALPHONSE [2], BABA-MOUSSA LAMINE [3], Seri Bialli [4], Gbéassor Messanvi [5], Khan Naim Akhtar [6],
Journal: Indian Journal of Applied Research
Catégorie Journal: Internationale
Impact factor: 2.1652
Volume Journal: 5
DOI: DOI: 10.15373/2249555X
Resume Background: The present study was undertaken to evaluate the anti-diabetic of sclerocarya birrea (A. Rich) Hochst in a diet-induced obesity (DIO) mouse model. Obesity-induced contributes to the development of obesity-related metabolic disorders such as insulin resistance, type 2 diabetes, fatty liver disease, and cardiovascular disease. In this study, we investigated whether sclerocarya birrea can reduce obesity-induced and metabolic disorders such as insulin resistance and hepatic steatosis. Methods: Male C57BL/6 obese mice fed a high-fat diet for 10 weeks were administered orally by gastric intubation sclerocarya birrea extract at a dose of 200 or 300 mg/kg body weight, for a further 10 weeks and were compared with HFD-control group. Diets were prepared freshly every week and stored at 4oC. The food and the water were provided ad libitum and replenished every 3-4 days. During the study, serum glucose level was measured at the same time in the morning. Serum insulin was determined using an ELISA kit, according to the manufacturer’s instructions. Serum glucose was determined by the glucose oxidase method using a glucose analyser. After liver lipid extraction according to the method of Folch et al., liver TG content was measured by using a commercially available kit. Free fatty acids (FFA) were separated on silica gel by thin layer chromatography (TLC). The purified fractions of FFA and TG were quantified by gas liquid chromatography. As well as liver and kidney functional parameters (ALT, AST, creatinine, alkaline phosphatase) were assessed. The expression of the liver protein was analyzed by Western blot. Results: At the end of the study, insulin sensitive tissue (liver) collected to investigate anti-diabetic effects and examine the plant’s molecular mechanisms. sclerocarya birrea also reduced Serum glucose. Noteworthy, 200 mg/kg sclerocarya birrea efficiently reduced glycaemia although plasma insulin levels were similar to diabetic controls while preventing hepatic steatosis (Sclerocarya birrea diminished hepatic triglyceride, free fatty acids) in DIO mice. Western immunoblot analysis, demonstrated that sclerocarya birrea stimulated two pathways: the insulin dependent Akt and the insulin independent AMPK ones. The improvement of hepatic steatosis observed in DIO treated mice was associated with a decrease in the hepatic content of SREBP-1, a transcription factor involved in de novo lipogenesis. Sclerocarya birrea treatment had tendency to increase hepatic PPARα levels beyond those of control DIO animals. Sclerocarya birrea treatment did not alter liver (ALT, AST) or renal (creatinine and alkaline phosphatase) functional parameters in the blood, thereby attesting to the lack of toxicity of the plant extract in diet-induced obesity mice. Conclusion: These data suggest that sclerocarya birrea exerts potential anti-diabetic action by improving insulin sensitivity and mitigating high-fat diet-induced obesity and hyperglycemia. They also validate the safety and efficacy of this plant.
Mots clés Mouse, sclerocarya birrea, type 2 diabetes mellitus, insulin resistance, DIO mice, Mouse, sclerocarya birrea, type 2 diabetes mellitus, insulin resistance, DIO mice,hyperglycemia, hyperinsulinemia, AKT, AMPK, SREBP-1, PPARα.
Pages 710 - 716

Publications par entité

  • Centre de Formation et de Recherche en matière de Population (CEFORP) (21)
  • Centre Interfacultaire de Formation et de Recherche en Environnement pour le Développement Durable (CIFRED) (43)
  • Chaire Internationale en Physique Mathématique et Applications (CIPMA-Chaire UNESCO) (45)
  • Ecole Doctorale Pluridisciplinaire <<Espaces, Culture et Développement>> (0)
  • Ecole Nationale d'Administration et de Magistrature (ENAM) (72)
  • Ecole Nationle d'Economie Appliquée et de Management (88)
  • Ecole Normale Supérieure (35)
  • Ecole Polytechnique d'Abomey-Calavi (EPAC) (1123)
  • Faculté de droit et de Science Politique (FADESP) (109)
  • Faculté des Lettres et Sciences Humaines (FLASH) (1376)
  • Faculté des Lettres, Langues, Arts et Communications (FLLAC) (0)
  • Faculté des Sciences Agronomiques (1906)
  • Faculté des Sciences de la Santé (FSS) (2213)
  • Faculté des Sciences Economiques et de Gestion (FASEG) (191)
  • Faculté des Sciences et Techniques (FAST) (1081)
  • Faculté des Sciences Humaines et Sociales (FASHS) (70)
  • Institut de Formation et de Recherche en Informatique (IFRI) (76)
  • Institut de Géographie de l'Aménagement du territoire et de l'Environnement (IGATE) (0)
  • Institut de Mathématiques et de Sciences Physiques (IMSP) (124)
  • Institut National de l'Eau (INE) (28)
  • Institut National des Métiers d'Art d'Archéologie et de la Culture (INMAAC) (11)
  • Institut National Médico Sanitaire ( INMeS) (0)
  • Institut Régional de Santé Publique (IRSP) (84)

Publications par sexe

  • Femme( 1395 )
  • Homme (